<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9"><gtr:id>4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9</gtr:id><gtr:name>Geron Corporation</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Sir William Dunn Sch of Pathology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9"><gtr:id>4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9</gtr:id><gtr:name>Geron Corporation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8D61EDAA-70A5-4AC4-A5FF-A8A3448C0FD0"><gtr:id>8D61EDAA-70A5-4AC4-A5FF-A8A3448C0FD0</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Jonathan</gtr:otherNames><gtr:surname>Fairchild</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802538"><gtr:id>D1CE800B-5FF3-45C4-B510-4165F5914191</gtr:id><gtr:title>The Immunobiology of Stem Cell Transplantation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802538</gtr:grantReference><gtr:abstractText>2006 proved to be an important turning point in the history of the UK since, for the first time, the number of people retired exceeded the number of children at school. While such a landmark may appear subtle, it heralds a new era in modern medicine necessary to deal with the increasing prevalence of diseases commonly associated with old age, such as macular degeneration, diabetes and Parkinson!
s disease. Given that embryonic stem cells (ESC) have the capacity to spawn any one of the 200 or so types of cells that make up the human body, they have been widely acclaimed to be the answer to the shortage of organs and tissues for transplantation, needed to deal with this rising tide of degenerative diseases. Nevertheless, their use poses some of the same problems that have confounded whole organ transplantation over the past 30 years, while raising further problems besides. As is the case for an organ from either a living or deceased donor, tissues grown from ESC will be recognised as foreign and vigorously rejected by the host!
s immune system. Unlike conventional tissues, however, ESC are closely related to cancer cells and may, therefore, pose an additional risk of turning into tumours once implanted into patients. Furthermore, the intervention required to prevent rejection and ensure survival of the tissue may substantially increase the risk of a patient developing cancer. Our recent research has uncovered a previously unappreciated property of tissues differentiated from ESC: their capacity to actively repel an immune response targeted against them. While these findings are good news for helping to outwit the host!
s immune response, they may also prevent the immune system from identifying and destroying any cells hidden within the tissue that are on the verge of turning cancerous. The purpose of our current research is, therefore, to quantify the risks involved by constructing tissues for grafting known to contain defined numbers of these rouge cells and investigating whether or not they can be sought out and destroyed by the host!
s immune system. The outcome of this project will be critical for informing strategies for the use of ESC-derived tissues that will maximise the therapeutic value for patients while minimising the risks involved.</gtr:abstractText><gtr:technicalSummary>Proposals to embark on the first Phase I clinical trials of cell replacement therapy (CRT) using tissues differentiated from human embryonic stem cells (ESC) have brought into sharp focus the technological barriers that still need to be addressed to maximise efficacy and minimise any risks to patients. In particular, the immunogenicity of tissues differentiated from allogeneic ESC remains a significant obstacle which threatens to undermine the likely benefits of regenerative medicine. Furthermore, the potential for rare cells, contained within the graft, to become tumorigenic remains a substantial concern. Our previous work, funded by the MRC, is of relevance to both of these issues, since it demonstrated unequivocally that tissues differentiated from mouse ESC display a fragile propensity for immune privilege due, in part, to their constitutive expression of TGF-?O2, capable of polarising infiltrating T cells towards a Treg phenotype in an antigen-specific fashion. Although the privileged status of these tissues is only sufficient to repel an immune response across a minor histocompatibility barrier, it is important for several reasons: we have, for instance, demonstrated how it is possible to exploit these natural properties to establish transplantation tolerance across far greater immunological barriers, including a full MHC disparity. Conversely, by affording a microenvironment conducive the regulation, tissues derived from ESC may protect any transformed cells they harbour from immune surveillance and immunological destruction: indeed, the induction of tolerance required to secure acceptance of the very tissue itself may paradoxically increase the risk of tumorigenesis. Here we propose to exploit well-established models of CRT, together with a comprehensive panel of mouse ESC, first derived through MRC funding, to quantify the risks involved and to compare the ability of two strategies for tolerance induction to spare immune responses to immunogenic antigens sequestered within the tissue. Furthermore, we propose to determine whether the properties we have uncovered for mouse ESC are shared by induced pluripotent stem cells (iPSC), thereby predisposing them towards tolerance induction but conferring on them the capacity to nurture tumour growth. Finally, in anticipation of the need for clinical translation of these findings, we propose to adapt our preclinical models to investigate the immune privileged properties of ESC and iPSC of human origin.</gtr:technicalSummary><gtr:fund><gtr:end>2011-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>517515</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Geron Corporation</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Differentiation of dendritic cells from human ES cells</gtr:description><gtr:id>9F182A02-9BD6-4F6A-AD28-E3C0A99D4323</gtr:id><gtr:impact>Publication in Regenerative Medicine PubMed Number: 19580370
Publication currently in press in Journal of Biomedicine and Biotechnology</gtr:impact><gtr:outcomeId>75C04CF9D93-1</gtr:outcomeId><gtr:partnerContribution>Provision of human ES cell lines under an appropriate MTA.</gtr:partnerContribution><gtr:piContribution>Optimization of protocols for the derivation of dendritic cells from human ES cells under animal product-free conditions and their subsequent characterisation.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Great Ormond Street Hospital (GOSH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>iPSC Derivation from Lysosomal Storage Disease Patients</gtr:description><gtr:id>A3DBC390-BCA6-4DCE-BA95-C8A33FA4B133</gtr:id><gtr:impact>This collaboration is too recent to have generated outputs.</gtr:impact><gtr:outcomeId>extbcnXY1rn-1</gtr:outcomeId><gtr:partnerContribution>Identification of appropriate donors, obtaining informed consent and providing dermal fibroblasts for reprogramming</gtr:partnerContribution><gtr:piContribution>On-going derivation of iPS cells from patients with Lysosomal Storage Diseases and their differentiation into dendritic cells.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public Outreach (Literary Festival)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B50543E3-4ADB-412E-A7D8-B39A89ADF994</gtr:id><gtr:impact>I was invited to contribute to a panel discussion as part of the Sunday Times Literary Festival which was made available online.

the debate encouraged significant on-going dialogue with members of the public</gtr:impact><gtr:outcomeId>EsU4xhzyfXv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools Outreach</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>44252A91-7D08-461F-BD6B-6B72638A7814</gtr:id><gtr:impact>Approximately 150 year 11-13 students from schools local to Banbury got together to consider issues relating to the use of stem cells in medicine.

During the course of the workshop, I was approached by several students who asked to visit my laboratory to investigate careers in science.</gtr:impact><gtr:outcomeId>QmSDWSJuSgm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 3</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6781753B-8186-4687-BE33-B7EBE53C7407</gtr:id><gtr:impact>Interviewed about my research which was published in an article in New Scientist (3 May 2008 pp40-43)

Undetermined</gtr:impact><gtr:outcomeId>B7F5A271871</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 2</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D910E0BF-FD9A-4487-B7FC-9B85BF8E84CB</gtr:id><gtr:impact>Interviewed about research which was described in an article for A level students published in Biological Sciences Review (18:6-9)

Undetermined</gtr:impact><gtr:outcomeId>ADFF059750C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 11</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0256ED11-0FBB-4C34-9F4F-F8651D651753</gtr:id><gtr:impact>Interviewed in The Guardian about recent developments in stem cell biology

Undetermined</gtr:impact><gtr:outcomeId>fU1fxZPMpkk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 16</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>09DDCFE8-B143-4B93-84F8-2F6AC01F8B31</gtr:id><gtr:impact>Invited comment in the Japan Times on the award of the Nobel Prize to stem cell biologists

Undetermined</gtr:impact><gtr:outcomeId>V7uL1Krd5Zb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture (Worcester)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9D347C66-6726-4F03-BEAC-487DC85568F0</gtr:id><gtr:impact>I was asked to speak about regenerative medicine to a faith-based interest group in Worcester which attracted approximately 10 people from around the city.

The presentation stimulated considerable discussion among members of the audience some of whom contacted me afterwards.</gtr:impact><gtr:outcomeId>YDuofAWU5my</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1F240D6B-B3DA-4274-910A-3349002CEF49</gtr:id><gtr:impact>Attended by an audience of 300 health professionals and members of the public

Numerous subsequent contacts made with individuals and invitations to speak at various organisations</gtr:impact><gtr:outcomeId>b6ARdMhVm9D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture (Cafe Scientifique)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>54333074-4FB5-4607-9E09-681D75B8CD09</gtr:id><gtr:impact>Approximately 100 members of the public attended my presentation on stem cells.

My presentation fostered considerable interest and on-going correspondence with several members of the audience.</gtr:impact><gtr:outcomeId>r6CoSsbeb4h</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cafescientifique.org/index.php?option=com_contentbuilder&amp;title=uk-henley&amp;controller=details&amp;id=1&amp;record_id=156&amp;Itemid=478&amp;limitstart=20&amp;filter_order=</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 18</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AD34F254-0454-484B-89C0-E894E26FD014</gtr:id><gtr:impact>Invited comment in The Scientist on the award of the Nobel Prize to stem cell biologists

Undetermined</gtr:impact><gtr:outcomeId>Vdkkt8CjCia</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 21</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CDDF3FD4-FA97-4C1E-B6DF-55CC349E143A</gtr:id><gtr:impact>Media coverage in the Jerusalem Post of the award of funding as part of the BIRAX Initiative

Undetermined</gtr:impact><gtr:outcomeId>B23UH7vUPLu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 23 (New Scientist)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>48276EFE-486D-494E-94BD-D8611CB68B77</gtr:id><gtr:impact>The article to which I contributed in New Scientist received significant interest online.

As a result of this article I received various emails from members of the public.</gtr:impact><gtr:outcomeId>tB3wm3D5NtQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Economic Forum - Dalian</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6DAF56CC-A00C-4AD8-95C1-8B2EA9D0E524</gtr:id><gtr:impact>Provision of two presentations on the future of regenerative medicine and participation in panel discussions with policy makers in the health sciences.

Potential collaborative ventures with Serbian govenment in the stem cell field. Numerous contacts with industry and govenment.</gtr:impact><gtr:outcomeId>D64BB906CB4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 14</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>73F4BAC5-177F-42F1-A405-969452407519</gtr:id><gtr:impact>Interviewed in an article published in Current Biology in my capacity as Director of the Oxford Stem Cell Institute

Undetermined</gtr:impact><gtr:outcomeId>nUimoGRKpWZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 24 (The Scientist)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AFDBF96E-77DF-473E-BFE6-AEBFC58824B3</gtr:id><gtr:impact>I contributed to an article that has fuelled an o-going debate concerning the immunogenicity of autologous iPS cells.

This article has been instrumental in raising awareness of the issues of immunogenicity in the stem cell field.</gtr:impact><gtr:outcomeId>EZNwnenTfMV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visits</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>42202CE9-FCFB-47E5-BBF5-892A6F9CB0DA</gtr:id><gtr:impact>Presentation of a morning workshop on stem cell research at various schools in and around Oxford including: - Oxford High School, Oxford - Henry Box School, Witney - Magdalen College School, Oxford - The Marlborough School, Woodstock - Matthew Arnold School, Oxford - The European School Culham

Significant interest among students to follow science as a career, as evidenced from feedback forms and follow-up.</gtr:impact><gtr:outcomeId>45BC12EDE0F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture (Liberal Democrats)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C529708A-B8AF-40FA-853B-30ED8BE17859</gtr:id><gtr:impact>I was invited to speak at the Liberal democrat Lawyers Association annual conference about the ethical issues surrounding stem cell research

My presentation was very well received and led to significant debate over the course of the two day conference.</gtr:impact><gtr:outcomeId>tCNnLneqPTv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 15</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9E099260-3379-417E-9F54-0F5CAE023BCF</gtr:id><gtr:impact>I was the subject of a two page spread in the Observer which discussed my ongoing research

Numerous contacts with members of the general public</gtr:impact><gtr:outcomeId>a6BNYnkBqrG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview 2</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FDC1C757-5B8D-47C7-A666-6F0067E1B0D7</gtr:id><gtr:impact>Interview with Robyn Williams of ABC Radio Australia

Personal contact with several listeners wanting more information about potential stem cell therapies</gtr:impact><gtr:outcomeId>321659B56F4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>ED912431-1A59-451C-B338-E2008314527F</gtr:id><gtr:impact>Approximately 100 students from Oxford High School attended a lecture on the the use of stem cells in the treatment of cancer, generating much subsequent discussion.

The school reported the best attendance they ever achieved for an event.</gtr:impact><gtr:outcomeId>XsgeC1YEGtm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV Interview</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6D961222-6429-40B1-8426-1F96E4EC949B</gtr:id><gtr:impact>Interviewd for Discovery Channel on developments in stem cell biology

Undetermined</gtr:impact><gtr:outcomeId>CCLqcMjUEpV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E6FC1DAC-3828-4213-BD9A-B058F8E344DC</gtr:id><gtr:impact>Approximately 100 CEOs of influencial businesses attended an evening event hosted by the Young Presidents Organisation (YPO) on the future of regenerative medicine, at which I was invited to speak

Considerable discussion with members of the audience and new contacts made which led to an invitation for me to join the Scientific Advisory Board of a company working in the field of cord blood stem cells.</gtr:impact><gtr:outcomeId>ZhEWQ48Pmbu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxfordshire Bioscience Network</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0730875A-961E-4F69-8E71-2E7F962DBBBC</gtr:id><gtr:impact>Showcasing of stem cell related technologies to CEOs of pharmaceutical companies in the Thames Valley region

Establishment of contacts with numerous commercial organisations and local MPs</gtr:impact><gtr:outcomeId>06E26A6C218</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview 4</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1D81A82C-00A2-4BF4-B30D-510011E7A914</gtr:id><gtr:impact>Interview on 'The World Tonight' on BBC Radio 4 about the future of regenerative medicine and its likely impact on society

Numerous contacts and discussion with members of the public</gtr:impact><gtr:outcomeId>ZhCWt91PeYZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 7</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A46E5EE1-2E71-4D10-BD29-581B4D6A240A</gtr:id><gtr:impact>Interviewed for a feature in Current Biology

Undetermined</gtr:impact><gtr:outcomeId>UxJkMczoMD9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview 1</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E55CB321-42FA-455A-99D8-AF40BBDF1561</gtr:id><gtr:impact>Interview with Bill Heine of BBC Radio Oxford

Numerous contacts by telephone and email with members of the public who had a personal interest in regenerative medicine</gtr:impact><gtr:outcomeId>D255661351F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview 3</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0FDB2524-0B5C-4CB0-B780-5B57060B8546</gtr:id><gtr:impact>Interviewed on the 'Today' programme on BBC Radio 4 about recent developments in stem cell biology published in Nature

Significant ongoing contact with members of the general public</gtr:impact><gtr:outcomeId>RGinyXT2TZH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 6</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>09B40C2E-815D-4CD8-96B6-9C3D80BB2634</gtr:id><gtr:impact>Featured in an article in the New Sabah Times in response to my presentation at the World Economic Forum in Dalian

Undetermined</gtr:impact><gtr:outcomeId>YXdEHF6nDQU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Economic Forum - Davos</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>55AC6C00-130D-4EA6-A6A5-5E8D8310479A</gtr:id><gtr:impact>Presentation of current challenges in stem cell biology and regenerative medicine. Involvement in panel discussions on policy in science and medicine.

Contacts with government officials and policymakers in various countries worldwide. Contact with the CEOs of many biotechnology companies.</gtr:impact><gtr:outcomeId>B22AAEC0A7C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F6AE4BFB-F150-4BB7-BBE9-4F23CD9AA27C</gtr:id><gtr:impact>Approximately 40 students attended the open day at which I was asked to speak about stem cell biology, which provoked considerable discussion.

As a result of the event, I was invited to visit a school to hold a workshop on stem cells. Furthermore, several students remain in email contact and are actively exploring a career in science and stem cell research in particular.</gtr:impact><gtr:outcomeId>MkLirEKZHpz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E98CD2AF-8E5F-4E91-BF15-AB38A4A82320</gtr:id><gtr:impact>Approximately 40 members of the public attended an evening event devoted to the future of regenerative medicine

Discussions with numerous members of the audience about the ethics of stem cell biology</gtr:impact><gtr:outcomeId>avbbkNfDuYn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 19</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0E43BC94-621D-4FF7-9A71-56B11320B880</gtr:id><gtr:impact>Invited comment in the Arab Times on the award of the Nobel Prize to stem cell biologists

Undetermined</gtr:impact><gtr:outcomeId>Sqxg2yT2eqQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 12</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CEDD56C7-47A2-4F08-A27A-F7934EF8F33C</gtr:id><gtr:impact>Interviewed by Nature about the implications of work published in the journal on the future of regenerative medicine

Undetermined</gtr:impact><gtr:outcomeId>b1zwAdXv9BK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 17</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BAF79FF1-41A1-4F5C-95CE-AA896C503C39</gtr:id><gtr:impact>Invited comment in the Sydney Morning Herald on the award of the Nobel Prize to stem cell biologists

Undetermined</gtr:impact><gtr:outcomeId>BiWjwXENq3s</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release 1</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>76697530-6AF5-4A5D-A51F-D3175E6A7590</gtr:id><gtr:impact>Press release for the UKNSCN inaugral meeting covering work funded by the MRC.

This press release has been published on numerous wesites for example: http://www.sciencedaily.com/releases/2008/04/080411082935.htm</gtr:impact><gtr:outcomeId>03107F11858</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Television Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B0E5C051-4AB3-475D-A80B-67F65103F2BE</gtr:id><gtr:impact>Interview about regenerative medicine and the issues of immunogenicity for the Russian NTV network

Undetermined</gtr:impact><gtr:outcomeId>2DA7120CC63</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 4</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F17C19A4-742D-4A59-9F7E-E2F23C4511F7</gtr:id><gtr:impact>Interviewed by the Science Editor of Die Welt which formed a whole page article published in the newspaper on 7 Feb 2009 (pW3)

Several contacts from members of the public</gtr:impact><gtr:outcomeId>3887E8DAD2C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 8</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CA974FEC-D2DB-4F6A-9A09-0167486F366D</gtr:id><gtr:impact>Interviewed by Research Fortnight about Peer Review with an aim to influencing national policy.

Issues addressed in the article were investigated by our MP, Dr Evan Harris, with a view to raising them in parliament.</gtr:impact><gtr:outcomeId>QB1n6oD8Gzs</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 5</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F77F5B01-6CD9-4E7D-9D6A-C3F796BFBC51</gtr:id><gtr:impact>Interviewed concerning recent developments in stem cell biology for Chemistry World

Undetermined</gtr:impact><gtr:outcomeId>jMneQ85XdGm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Release 2</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F07BC160-4603-492A-B91B-2BA2A1743853</gtr:id><gtr:impact>Pess release in conjunction with Geron Corporation announcing the derivation of dendritic cells from human ES cells using protocols compatible with their clinical use

The press release contributed to the raising of venture capital by Geron Corporation</gtr:impact><gtr:outcomeId>56D3D942EFF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Release 3</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1B744458-AD01-45CD-A4FB-FAFC962A2ADE</gtr:id><gtr:impact>Publication of our paper in Gene Therapy was covered by the BBC News Online

Unsolicited contacts from members of the public interested in finding out more about our research</gtr:impact><gtr:outcomeId>tXatVDFKpb3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 1</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>08AE5E37-B0B9-49E5-9E44-C96D289A8EB4</gtr:id><gtr:impact>Interviewed by Nature and research described in a News Feature (Nature 439:652)

Undetermined</gtr:impact><gtr:outcomeId>69E241A5C37</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A138E899-EB77-4F00-9951-BC955ABF0DFC</gtr:id><gtr:impact>Invitation to speak at the Cirencester Science and Technology Society on 'Stem Cells and the Promise of Regenerative Medicine' which attracted a full-capacity audience made up exclusively of members of the general public.

Numerous contacts with members of the public.</gtr:impact><gtr:outcomeId>TMsadhofkjY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 22</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>440ADEF4-10B3-4721-9E3F-D9B51ADCF939</gtr:id><gtr:impact>Media coverage in Jewish Chronicle of the award of funding as part of the BIRAX Initiative

Undetermined</gtr:impact><gtr:outcomeId>PpBPSX7xtuk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 20</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2B9CBD10-9EB2-45B5-ABE7-24AC1703E1EF</gtr:id><gtr:impact>Media coverage in the Times of Israel of the award of funding as part of the BIRAX Initiative

Undetermined</gtr:impact><gtr:outcomeId>bAjuqrfbLa9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture (Global Scholars)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D19B0373-BC74-44B2-9418-639BD623DED9</gtr:id><gtr:impact>I was invited to speak about recent advances in stem cell research to approximately 100 Rhodes , Fulbright and Clarendon Scholars at the University of Oxford

The presentation sparked significant interest and debate.</gtr:impact><gtr:outcomeId>PfzUYs4NV9G</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 9</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>99169DA9-F922-4A8D-A7BC-0B58E4BB8E83</gtr:id><gtr:impact>Interviewed for an article in Spektrum, the german speaking edition of Scientific American, about the ethics of stem cell biology

Undetermined</gtr:impact><gtr:outcomeId>hXnVU2ZY2yH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Venturefest</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F259A5ED-0FF3-4191-89EA-6373356F12B2</gtr:id><gtr:impact>Discussion of research funded by the MRC, its application to regenerative medicine and opportunities for commercial exploitation

Development of contacts with venture capitalists</gtr:impact><gtr:outcomeId>E77B9918DEC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Outreach</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>86664FF2-C12A-428D-85CE-56DB11E9AEBF</gtr:id><gtr:impact>Invited to speak at the Faraday Institute, University of Cambridge on the ethics of stem cell biology.

Considerable interest expressed and contacts made among the 100 who attended.</gtr:impact><gtr:outcomeId>raKvJfN2WAK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article 10</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>84F98E79-C26C-429C-B075-11975C1B9FA7</gtr:id><gtr:impact>Interviewed for an article on stem cells and regenerative medicine in the subscription magazine B Beyond.

Undetermined</gtr:impact><gtr:outcomeId>LUmKfLy1K7u</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Outreach</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5B526C46-DDD5-4639-ADB7-926523B96EA0</gtr:id><gtr:impact>Provided keynote lecture at the European Biology Teachers Convention in Frankfurt on the future of regenerative medicine.

Made many new contacts and invitations to visit schools around Europe.</gtr:impact><gtr:outcomeId>fPy7wB3Aays</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Britain Israel Research Academic Exchange (BIRAX)</gtr:department><gtr:description>BIRAX Regenerative Medicine Initiative</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:fundingRef>09BX12PFYR</gtr:fundingRef><gtr:id>B3191AFA-32B0-494A-9A20-AF9812CC4051</gtr:id><gtr:outcomeId>j4utWvqVTCT</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>19810</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2009 Seed Funding Initiative</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>FF8B0B9A-FF83-4DBC-884B-582806DADA5E</gtr:id><gtr:outcomeId>907EF5240100</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2008 Seed Funding Inititative</gtr:description><gtr:end>2010-02-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>9D50F147-8E3A-4705-8E4F-22A05BCB4F57</gtr:id><gtr:outcomeId>D823C2ECF5B0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>738000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Capacity Building Studentships</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>BE8F179D-F8AB-4571-9ADD-B3CEB621AEDB</gtr:id><gtr:outcomeId>D9DAFF0ED300</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We have developed protocols for the differentiation of a novel population of dendritic cells from human iPS cells capable of the cross-presentation of soluble antigen</gtr:description><gtr:grantRef>G0802538</gtr:grantRef><gtr:id>F1D50016-9DED-499B-AF8A-51C1368D8AC0</gtr:id><gtr:impact>Too early to determine</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>DxsEusoZq32</gtr:outcomeId><gtr:patentId>WO2012127206</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Differentiation of cross presenting dendritic cells from iPS cells</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Standards Institute - PAS 84</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5FDEA553-C283-4401-9DC2-5A07738EBED6</gtr:id><gtr:outcomeId>Vp6gSBocicp</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chatham House</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EEE2F88D-C7B0-45FD-AE36-13BBC433482F</gtr:id><gtr:outcomeId>i1hg4Qav8PH</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>House of Lords Select Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0ABC139E-3519-43A5-8147-B07CDBC775B7</gtr:id><gtr:outcomeId>aqgVEcoF5qS</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC-NSFC Collaboration</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6264B17A-7ABF-4DC9-890C-6D9B950259DD</gtr:id><gtr:outcomeId>PvJ2jE1Rz8V</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>RCUK/TBS Forward Look in Regenerative Medicine</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B467EE73-23B0-430C-8090-898238A023F0</gtr:id><gtr:outcomeId>AuvaXwXpe7h</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Interantional Working Group on Establishment of an iPSC Haplobank</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>08FBE480-4445-4DC6-A32F-2CD388B87118</gtr:id><gtr:outcomeId>G7rhjYZNX3N</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cell and Gene Therapy Catapult Annual SAB Meeting</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AE01D6F4-B4AB-4A61-B16E-F3592A829AC4</gtr:id><gtr:outcomeId>58c470634f0a34.62190165</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Working Together on MSC Standards: A UK/US/Canada-led Initiative</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AC91C967-2241-4D9B-8CD1-B5A1DC13A4C4</gtr:id><gtr:outcomeId>q9CPnWjX9wQ</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Department of Health GTAC</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>36AA93C2-834D-4277-885B-04868EF25E71</gtr:id><gtr:outcomeId>hKjGJqEKhud</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UK-Spanish Collaboration</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>A5997951-2106-43BA-82E7-A1B47AFF01B1</gtr:id><gtr:outcomeId>tUoZrMHyzsG</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have generated 95 novel ES cell lines from various strains of mice, both genetically modified and wild type. Many of these strains, such as the NOD mouse, have previously been considered non-permissive: these lines therefore represent a significant resource for the medical research community.</gtr:description><gtr:id>623DA042-100F-4998-87AB-0717E23F7ACD</gtr:id><gtr:impact>Nascent collaborations with various groups</gtr:impact><gtr:outcomeId>D2170262F46</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mouse ES cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have generated a number of induced pluripotent stem cell lines from various mouse strains with important properties for the study of immune privilege</gtr:description><gtr:id>60785DB6-154F-4594-8719-3A980D49B0C7</gtr:id><gtr:impact>Cell lines will be made available to interested research groups</gtr:impact><gtr:outcomeId>idRXwt6FYvP</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mouse iPS Cell Lines</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DAA38EE3-02DE-4BFA-B7B0-09FE0876FC12</gtr:id><gtr:title>Rapamycin conditioning of dendritic cells differentiated from human ES cells promotes a tolerogenic phenotype.</gtr:title><gtr:parentPublicationTitle>Journal of biomedicine &amp; biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/334bb3fa06ba7049928f293fe6c4d46a"><gtr:id>334bb3fa06ba7049928f293fe6c4d46a</gtr:id><gtr:otherNames>Silk KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1110-7243</gtr:issn><gtr:outcomeId>pm_15574_24_22505805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEAAFA47-F8AD-493F-AEF7-E1CF7F9F703B</gtr:id><gtr:title>The Immunological Barriers to Regenerative Medicine</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aabd38d22ef90645151cece851cdb1b"><gtr:id>9aabd38d22ef90645151cece851cdb1b</gtr:id><gtr:otherNames>Fairchild PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-4614-5479-3</gtr:isbn><gtr:outcomeId>QMMhYxYo9R1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A052E88-305A-4717-B07B-7F05B422F130</gtr:id><gtr:title>Transplantation tolerance in an age of induced pluripotency.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aabd38d22ef90645151cece851cdb1b"><gtr:id>9aabd38d22ef90645151cece851cdb1b</gtr:id><gtr:otherNames>Fairchild PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>54712060213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FEAE3DC-88F6-434F-A72F-E7F7952A1CE3</gtr:id><gtr:title>Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aad47ac13f2362b1f5cf818ca4c17946"><gtr:id>aad47ac13f2362b1f5cf818ca4c17946</gtr:id><gtr:otherNames>Yates SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>369B77B7D27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFA6739F-09E2-4C4B-8782-45D6A736650E</gtr:id><gtr:title>The challenge of immunogenicity in the quest for induced pluripotency.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aabd38d22ef90645151cece851cdb1b"><gtr:id>9aabd38d22ef90645151cece851cdb1b</gtr:id><gtr:otherNames>Fairchild PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>PsBK1fk7qT6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43108D6B-72B4-438F-8CCD-D3D378E21195</gtr:id><gtr:title>Ectopic transplantation of tissues under the kidney capsule.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c9ee0469e4235765d6d620108426297"><gtr:id>7c9ee0469e4235765d6d620108426297</gtr:id><gtr:otherNames>Robertson NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>4006722CC3E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD7CD938-8B2D-415C-B32F-42883C9D8F11</gtr:id><gtr:title>Harnessing dendritic cells for the induction of transplantation tolerance.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/334bb3fa06ba7049928f293fe6c4d46a"><gtr:id>334bb3fa06ba7049928f293fe6c4d46a</gtr:id><gtr:otherNames>Silk KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>109A24670DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67B47418-4113-49B6-9565-44ED82BC6C82</gtr:id><gtr:title>Infectious tolerance via the consumption of essential amino acids and mTOR signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffceb12522ddfcc1b45e3dd4aa6349eb"><gtr:id>ffceb12522ddfcc1b45e3dd4aa6349eb</gtr:id><gtr:otherNames>Cobbold SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>509D02D92A9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4529F16-4422-417B-B027-5E0D3B1F78E7</gtr:id><gtr:title>Immune privilege induced by regulatory T cells in transplantation tolerance.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffceb12522ddfcc1b45e3dd4aa6349eb"><gtr:id>ffceb12522ddfcc1b45e3dd4aa6349eb</gtr:id><gtr:otherNames>Cobbold SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>4D42700F2E8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F63177E3-F81D-4ED2-97D1-344465A9429F</gtr:id><gtr:title>A role for regulatory T cells in acceptance of ESC-derived tissues transplanted across an major histocompatibility complex barrier.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/760d02a5d76154f04677d338e441b556"><gtr:id>760d02a5d76154f04677d338e441b556</gtr:id><gtr:otherNames>Lui KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>mcUckNXTGKP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EE2A5E1-AEE3-4A3A-B0B3-0ED59B89839C</gtr:id><gtr:title>Pharmacological manipulation of dendritic cells in the pursuit of transplantation tolerance.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a54874861289bdeab44cf7d0793910a0"><gtr:id>a54874861289bdeab44cf7d0793910a0</gtr:id><gtr:otherNames>Leishman AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>RA5NVkdVsC5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A29EA72F-5943-4622-BD02-9FEFD949E4A3</gtr:id><gtr:title>Tolerogenicity is not an absolute property of a dendritic cell.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2eb04a0ddbd30b517dbc08a9fee2f213"><gtr:id>2eb04a0ddbd30b517dbc08a9fee2f213</gtr:id><gtr:otherNames>Farquhar CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>Li56H6Dr6Ve</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBBB2FF7-FD68-433C-8C7A-67AE70115E6A</gtr:id><gtr:title>Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c9ee0469e4235765d6d620108426297"><gtr:id>7c9ee0469e4235765d6d620108426297</gtr:id><gtr:otherNames>Robertson NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>CE0CBC8E051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>526BFA4B-AFAC-4EFD-B065-F500D5AD9A17</gtr:id><gtr:title>Genetic modification of dendritic cells through the directed differentiation of embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aabd38d22ef90645151cece851cdb1b"><gtr:id>9aabd38d22ef90645151cece851cdb1b</gtr:id><gtr:otherNames>Fairchild PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>DCB7EADE61F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECB79613-C8CB-4303-ABCA-D330448BDFC4</gtr:id><gtr:title>Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning.</gtr:title><gtr:parentPublicationTitle>BMC immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55cb81482fca6addc32b937c7fb498ce"><gtr:id>55cb81482fca6addc32b937c7fb498ce</gtr:id><gtr:otherNames>Graca L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-2172</gtr:issn><gtr:outcomeId>46A04B5C85B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB461174-128E-40A5-A6B0-7C4E9A301487</gtr:id><gtr:title>Infectious tolerance and the long-term acceptance of transplanted tissue.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d0f3b566b3dd22bba4cd03cf55c23ee"><gtr:id>2d0f3b566b3dd22bba4cd03cf55c23ee</gtr:id><gtr:otherNames>Waldmann H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>3C4A68A84F8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89BC6F95-034C-462C-BC89-FE79E756D7ED</gtr:id><gtr:title>Interaction of Salmonella typhimurium with dendritic cells derived from pluripotent embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fd994d84717a5372762ff6873b4c1ac"><gtr:id>9fd994d84717a5372762ff6873b4c1ac</gtr:id><gtr:otherNames>Rossi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_15574_ne_0052232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22B749FC-E260-417A-B33D-C00E9AB15445</gtr:id><gtr:title>Immune privilege of stem cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f9241562ffe00c001bdc67757201d88"><gtr:id>5f9241562ffe00c001bdc67757201d88</gtr:id><gtr:otherNames>Ichiryu N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>doi_15574_03_478_4_1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9843DCAA-7B01-4943-A817-AFCF031E0302</gtr:id><gtr:title>Optimization of protocols for derivation of mouse embryonic stem cell lines from refractory strains, including the non obese diabetic mouse.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60a1b1feee6b4bab1e806586c275e3b8"><gtr:id>60a1b1feee6b4bab1e806586c275e3b8</gtr:id><gtr:otherNames>Davies TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>Fsc5BiwqKBC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8E8FD46-2A3D-4E7C-8AD3-E48E8082C36C</gtr:id><gtr:title>Regulation and privilege in transplantation tolerance.</gtr:title><gtr:parentPublicationTitle>Journal of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d0f3b566b3dd22bba4cd03cf55c23ee"><gtr:id>2d0f3b566b3dd22bba4cd03cf55c23ee</gtr:id><gtr:otherNames>Waldmann H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0271-9142</gtr:issn><gtr:outcomeId>C08B3EF87F1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>037637A3-F9E6-477C-AF61-3BE54B54028B</gtr:id><gtr:title>The Immunological Barriers to Regenerative Medicine</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01c6b820553a7ee173b494064d25e1cd"><gtr:id>01c6b820553a7ee173b494064d25e1cd</gtr:id><gtr:otherNames>Hackett S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>978-1-4614-5479-3</gtr:isbn><gtr:outcomeId>JjwSPxaLNkQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5707F0E1-06B4-4AE3-B7F0-E4D49088447E</gtr:id><gtr:title>Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies.</gtr:title><gtr:parentPublicationTitle>Expert review of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c858c4b53406db467277a9e9c38f4543"><gtr:id>c858c4b53406db467277a9e9c38f4543</gtr:id><gtr:otherNames>Boyd AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1744-666X</gtr:issn><gtr:outcomeId>BoYDMMiycTb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAD932BE-5C82-4F2E-9F38-E4294F901831</gtr:id><gtr:title>Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b826733a753cd241606247afc5487101"><gtr:id>b826733a753cd241606247afc5487101</gtr:id><gtr:otherNames>Tseng SY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>DA846E33899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE08B013-010E-4D8B-A8AF-C892CCC36B52</gtr:id><gtr:title>Regulatory T cells in transplantation.</gtr:title><gtr:parentPublicationTitle>Seminars in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d0f3b566b3dd22bba4cd03cf55c23ee"><gtr:id>2d0f3b566b3dd22bba4cd03cf55c23ee</gtr:id><gtr:otherNames>Waldmann H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1044-5323</gtr:issn><gtr:outcomeId>541AACDDC41</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9424E0C-A424-42DF-9193-B128F658892C</gtr:id><gtr:title>Differentiation of dendritic cells from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/334bb3fa06ba7049928f293fe6c4d46a"><gtr:id>334bb3fa06ba7049928f293fe6c4d46a</gtr:id><gtr:otherNames>Silk KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>DoRsT3HsDy4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03368391-B7DC-4823-93BD-BC4FE16D4823</gtr:id><gtr:title>Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.</gtr:title><gtr:parentPublicationTitle>Expert review of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cee7452eb96c6cf00e1815629a21e81"><gtr:id>5cee7452eb96c6cf00e1815629a21e81</gtr:id><gtr:otherNames>Sachamitr P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1744-666X</gtr:issn><gtr:outcomeId>pm_15574_24_22992149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EA6FF0B-E050-44FA-95C0-8616C7C1C0B1</gtr:id><gtr:title>Human induced pluripotent stem cells are capable of B-cell lymphopoiesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f711e8c3bb4f3993ea48b4196244ab6e"><gtr:id>f711e8c3bb4f3993ea48b4196244ab6e</gtr:id><gtr:otherNames>Carpenter L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>j95ckyq6TPi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D838EB3B-7B96-4897-9EC9-07F09381AF63</gtr:id><gtr:title>Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3752efc5fb61a009a0543bcc6c98b658"><gtr:id>3752efc5fb61a009a0543bcc6c98b658</gtr:id><gtr:otherNames>J. T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-953-307-196-1</gtr:isbn><gtr:outcomeId>jGVQSiFZVU4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB4A0012-BD73-40B2-939E-357D2921F315</gtr:id><gtr:title>Prospects for ensuring acceptance of ES cell-derived tissues</gtr:title><gtr:parentPublicationTitle>StemBook</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcf182ba9d073bad09eb8ced3bb6eaa0"><gtr:id>dcf182ba9d073bad09eb8ced3bb6eaa0</gtr:id><gtr:otherNames>Lui Kathy O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>HZv4eRWX1Lt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5EDA3EA-72A9-4243-93B3-96B63E189301</gtr:id><gtr:title>Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/334bb3fa06ba7049928f293fe6c4d46a"><gtr:id>334bb3fa06ba7049928f293fe6c4d46a</gtr:id><gtr:otherNames>Silk KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>gvV8Shtv9xd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>594917A7-DE0A-4AB1-AF62-70306659F612</gtr:id><gtr:title>Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141Subset.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cee7452eb96c6cf00e1815629a21e81"><gtr:id>5cee7452eb96c6cf00e1815629a21e81</gtr:id><gtr:otherNames>Sachamitr P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a6f2f67102680.80903869</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96B9F68F-F4A6-4C04-BBFE-2206276D2B7A</gtr:id><gtr:title>Embryonic stem cells: protecting pluripotency from alloreactivity.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aabd38d22ef90645151cece851cdb1b"><gtr:id>9aabd38d22ef90645151cece851cdb1b</gtr:id><gtr:otherNames>Fairchild PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>8F4C3B0BD53</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDA6EF05-7DA3-4FCD-852B-10E0D77D5DF2</gtr:id><gtr:title>Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy.</gtr:title><gtr:parentPublicationTitle>Current stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/760d02a5d76154f04677d338e441b556"><gtr:id>760d02a5d76154f04677d338e441b556</gtr:id><gtr:otherNames>Lui KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1574-888X</gtr:issn><gtr:outcomeId>30B4D80A59C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97B9B4BF-1DA7-477F-B1BC-70A11ADFCF72</gtr:id><gtr:title>The Immunological Barriers to Regenerative Medicine</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f3e019c47d22a47c75edcb2e0190cc3"><gtr:id>9f3e019c47d22a47c75edcb2e0190cc3</gtr:id><gtr:otherNames>Fairchild P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>978-1-4614-5479-3</gtr:isbn><gtr:outcomeId>cikN8iuQvzU</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802538</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>